Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ribo Life Science Forms $2 Billion siRNA Collaboration with Boehringer Ingelheim

publication date: Jan 3, 2024

Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim that will apply its siRNA expertise to develop novel treatments for nonalcoholic or metabolic dysfunction-associated steatohepatitis (NASH/MASH) in a deal that could be worth up to $2 billion. Ribo will receive an upfront payment plus milestones and royalties for developing multi-target candidates. The agreement will include Ribocure AB, a Swedish subsidiary of Ribo Life Science that develops siRNA molecules. Ribocure uses its vertically integrated oligonucleotide research platform to deliver new candidates efficiently. In 2022, it advanced three projects to clinical stage in 20-24 months from concept to implementation. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here